At a glance
ClinicalIndex Comparison Record- ✓Adults age ≥18 years
- ✓Diagnosis of gynecologic or gastrointestinal cancer receiving anti-neoplastic therapy
- ✓Currently hospitalized, recently hospitalized (within first 2 visits after hospitalization), or recent outpatient placement of tube, line, or drain
- ✓Complex care needs such as ostomy, ileostomy, gastric tube, percutaneous nephrostomy tubes, PleurX catheter, or total parenteral nutrition
- ✕Unable to read and respond to questions in English
- ✕Cognitive impairment
- ✕Unable to complete baseline interview
- ✕Plan for immediate hospice referral
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
In Brief
A clinical study evaluating BOLSTER and Enhanced Discharge Planning (EDP) for Gynecologic Cancer and Gastrointestinal Cancer. Completed, enrolled 121 participants across 1 site.
Detailed Summary
This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.
Study Details
Timeline
Interventions
BOLSTER provides patients and caregivers with education and skills training, symptom management, and support across care settings over a four-week period.
EDP provides patients and caregivers a single session of education and skills training, symptom management, and support.